Merck
  • Home
  • Search Results
  • Development of a novel genetically modified bioluminescent-bacteria-based assay for detection of fluoroquinolones in animal-derived foods.

Development of a novel genetically modified bioluminescent-bacteria-based assay for detection of fluoroquinolones in animal-derived foods.

Analytical and bioanalytical chemistry (2014-10-31)
Guyue Cheng, Xiaobing Dong, Yulian Wang, Dapeng Peng, Xu Wang, Haihong Hao, Shuyu Xie, Wei Qu, Zhenli Liu, Zonghui Yuan
ABSTRACT

Fluoroquinolones (FQNs) are broad-spectrum antibacterial agents widely used in animal husbandry and aquaculture. The residues and antimicrobial resistance of such antibiotics are a major public health concern. To realize multianalyte detection of FQN residues, a genetically modified bacterium, Escherichia coli pK12 harboring plasmid pRecAlux3, was constructed in this study to develop a bioluminescent-bacteria-based assay for the detection of FQNs in animal-derived foods. This assay was based on the principle of induction of an SOS response by FQNs via inducing the recA-promoter-fused luciferase reporter gene existing on the plasmid pRecAlux3. E. coli pK12 was able to recognize 11 FQNs: difloxacin, enrofloxacin, ciprofloxacin, sarafloxacin, norfloxacin, danofloxacin, ofloxacin, pefloxacin, lomefloxacin, marbofloxacin, and orbifloxacin. This method could be applied to 11 edible tissues, including milk, fish muscle, and the muscles, livers, and kidneys of cattle, chickens, and pigs, with a very simple and rapid sample extraction procedure using only phosphate-buffered saline. The limits of detection of the FQNs were between 12.5 and 100 μg kg(-1), all of which were lower than the maximum residue limits. Most of the recoveries of the FQNs were in the range from 60 to 120 %, and the interassay coefficients of variation were less than 30 %. This method, confirmed by high-performance liquid chromatography, is reliable and can be used as both a screening test and a semiquantitative assay, when the identity of a single type of FQN is known.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Erythromycin, BioReagent, suitable for cell culture
Sigma-Aldrich
Erythromycin standard solution, 1 mg/mL in H2O
Sigma-Aldrich
Erythromycin, tested according to Ph. Eur.
Supelco
Sulfaquinoxaline, PESTANAL®, analytical standard
Sigma-Aldrich
Ampicillin, meets USP testing specifications
Supelco
Sulfamethazine, VETRANAL®, analytical standard
Sigma-Aldrich
Sulfamethazine, 99.0-101.0% (on dried basis)
Sigma-Aldrich
Erythromycin, potency: ≥850 μg per mg
Sigma-Aldrich
Erythromycin, meets USP testing specifications
Supelco
Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material
Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard
USP
Erythromycin, United States Pharmacopeia (USP) Reference Standard
Supelco
Marbofloxacin, VETRANAL®, analytical standard
Enrofloxacin for system suitability, European Pharmacopoeia (EP) Reference Standard
USP
Sulfaquinoxaline, United States Pharmacopeia (USP) Reference Standard
Marbofloxacin, European Pharmacopoeia (EP) Reference Standard
Marbofloxacin for peak identification, European Pharmacopoeia (EP) Reference Standard
Norfloxacin for system suitability, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Oxolinic acid, quinolone antibiotic
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Supelco
Norfloxacin, analytical standard, ≥98% (TLC)
Sigma-Aldrich
Ampicillin, anhydrous, 96.0-102.0% (anhydrous basis)
Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
Sigma-Aldrich
Enrofloxacin, ≥99.0%
Sigma-Aldrich
Nalidixic acid, ≥98%
USP
Ofloxacin, United States Pharmacopeia (USP) Reference Standard
Ofloxacin, European Pharmacopoeia (EP) Reference Standard
USP
Ampicillin, United States Pharmacopeia (USP) Reference Standard
Supelco
Enrofloxacin, VETRANAL®, analytical standard
Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard